North America Commanded the Largest Share 39.9% of the Global Defibrillators Market In 2014

Date: 2015-08-19

“The global defibrillators market is estimated to grow at a CAGR of 6.9% from 2014 to 2019. Although mature markets such as the U.S., Germany, Japan, and the U.K. held larger shares in the defibrillators market in 2014, the emerging countries in the Asia-Pacific market are poised to grow at the highest rate in the next five years. Factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and huge burden of cardiovascular disease are propelling the growth of these countries.

The global defibrillators market growth is driven by the development of technologically advanced defibrillators, rapid growth in aging population with high risk of target diseases, rising incidences of cardiovascular disease, growing focus of public and private organizations and key market players toward public access defibrillators, and increasing number of training and awareness programs across the globe. Moreover, emerging markets such as China, India, Brazil, and Mexico; home-use defibrillators; and development of subcutaneous implantable cardioverter defibrillators (S-ICDs) are creating opportunities for market growth.   However, lack of awareness about sudden cardiac arrests, issues related to the use of defibrillator devices (external and implantable), and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. 

In this report, the global defibrillators market has been segmented on the basis of products and end users. On the basis of products, the defibrillators market is segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The implantable cardioverter defibrillators segment is further bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The external defibrillators segment is segmented into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). On the basis of end users, the market is segmented into hospitals, prehospitals, public access markets, alternate care markets, and homes. 

Geographically, North America (comprising the U.S. and Canada) commanded the largest share—39.9%—of the global defibrillators market in 2014, followed by Europe. The North American defibrillators market is primarily driven by continuous technological advancements and product innovations, increasing number of public defibrillation programs, increasing prevalence of obesity, and rising focus of key players to expand their businesses in the North American region. However, stringent regulatory policies for approval of defibrillators, rising preference by public and private organizations for bulk purchases through group purchasing organizations (GPOs) and Integrated Health Networks (IHNs), and saturation of the market due to the presence of numerous players is restraining the growth of the defibrillators market in this region. 

The global defibrillators market is highly competitive. Medtronic, Inc. (U.S.) dominated the global defibrillators market in 2013, followed by St. Jude Medical, Inc. (U.S.). Other players include Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Sorin Group (Italy), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Nihon Kohden Corporation (Japan), and HeartSine Technologies, Inc. (U.S.). Agreements, partnerships, collaborations, contracts, and joint ventures; new product launches; geographical expansions; and strategic acquisitions are the major strategies adopted by market players to achieve growth in the defibrillators market.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample